Radial Artery Hemostasis Set Received Re-registration Certificate
Recently, Shanghai MicoPort Medical (Group) Co., Ltd. (hereinafter referred as MicroPort) received re-registration certificate issued by the State Food and Drug Administration (SFDA Category II, 2013 No. 2540303) for Radial Artery Hemostasis set. The validity period is through February 7, 2017.
Radial Artery Hemostasis set is independently developed and manufactured by MicroPort. It is mainly used to stop bleeding after the needle puncture in a minimally invasive surgery such as coronary angiography or percutaneous coronary interventional procedures. The product received its first registration in January 2010. Due to the category change in SFDA for certain products, Radial Artery Hemostasis set has been upgraded to the category II, therefore the additional clinical data pertaining to categorical change was required for receiving re-registration certificate. The upgrade represents the increasing requirement of product manufacturing control, quality management and additional clinical applications for MicroPort's Radial Artery Hemostasis set.
Privacy settings
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.
For more information, please see our Cookie Policy.